weekly_pin
TL2 Regular · Hull, UK
Same day, same time, eighteen months. Boring by design.
Joined 15 May 2025 · last posted 3d
92 posts, newest first. Showing up to 150.
-
A structured critique template this community uses — a second dataset Replied, post #49 · Evidence › Study critique · 25 Jul 2026 · 0 likes Picking up post #46: that is the part I would want checked first. Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with…
-
Insurance and replacement policies, compared Replied, post #108 · Sourcing › Logistics · 22 Jul 2026 · 12 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
What a certificate commits its issuer to Replied, post #55 · Analytics › COA interpretation · 18 Jul 2026 · 12 likes Picking up post #52: that is the part I would want checked first. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined…
-
What a reversed-phase purity number actually is Replied, post #45 · Analytics › HPLC & UHPLC · 11 Jul 2026 · 26 likes Worth separating two things that post #41 runs together. On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #40 · Pharmacology › Receptor biology · 10 Jul 2026 · 29 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #74 · Compounds › Oral incretins · 4 Jul 2026 · 2 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Publication patterns in the BPC-157 literature, examined Replied, post #26 · Compounds › Repair & healing peptides · 2 Jul 2026 · 8 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #11 · Clinical › Bloodwork · 30 Jun 2026 · 5 likes On post #7 — agreed on the reasoning, with one qualification. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone…
-
Batch numbers that do not match the vial label — what changed since Replied, post #42 · Sourcing › Red flags · 20 Jun 2026 · 6 likes I read post #40 twice before replying, because I had assumed the opposite. Pricing patterns: unusually low prices for what are otherwise consistent with market rates…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #51 · Practice › Dosing & titration · 18 Jun 2026 · 0 likes I read post #49 twice before replying, because I had assumed the opposite. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly…
-
Does a peptide degrade silently, with no visual change? Replied, post #48 · Practice › Storage & stability · 15 Jun 2026 · 16 likes post #47 is right about the mechanism and I think understates the practical bit. Beyond-use dating: the date after which a prepared solution should not be used. It is…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #26 · Evidence › Meta-analyses · 10 Jun 2026 · 0 likes Worth separating two things that post #22 runs together. When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or…
-
Racemisation and why it is invisible to a mass measurement Replied, post #26 · Analytics › Impurities & related substances · 9 Jun 2026 · 24 likes Coming back to post #24, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #60 · Sourcing › Red flags · 9 Jun 2026 · 4 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #23 · Start Here › How to Ask · 6 Jun 2026 · 3 likes post #22 answers the question as asked. The question underneath it is different. What you have already read matters. Saying "I read the maintained page on this and I…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #56 · Sourcing › Red flags · 5 Jun 2026 · 0 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
Private prescribing in the UK: what is actually involved Replied, post #27 · Regional › UK & Ireland · 31 May 2026 · 12 likes Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand…
-
Why we ask for units every single time, with three examples of what goes wrong Started this topic · Start Here › How to Ask · 25 May 2026 · 1 like Why we ask for units every single time, with three examples of what goes wrong — that is the question, and I have not found it answered plainly anywhere I have looked.…
-
The best-written scientific paper you have read Replied, post #56 · Lounge › Off topic · 20 May 2026 · 28 likes On post #52 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Tracking intake honestly when appetite is absent Replied, post #28 · Nutrition & Training › Protein & intake · 17 May 2026 · 0 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
What steady state means for the decision to escalate Replied, post #2 · Practice › Dosing & titration · 15 May 2026 · 5 likes On the opening post — agreed on the reasoning, with one qualification. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological…
-
Alcohol: what is documented and what is folklore Replied, post #11 · Practice › Interactions · 13 May 2026 · 6 likes I read post #9 twice before replying, because I had assumed the opposite. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #20 · Practice › Reconstitution · 20 Apr 2026 · 24 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Constipation management, with a dietitian's contribution Replied, post #54 · Practice › Side effects · 18 Apr 2026 · 11 likes post #53 answers the question as asked. The question underneath it is different. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain,…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #52 · Sourcing › Vendor reports · 17 Apr 2026 · 0 likes This follows post #49 rather than contradicting it. Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #12 · Practice › Reconstitution · 15 Apr 2026 · 9 likes Picking up post #9: that is the part I would want checked first. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #78 · Research Methods › Statistics · 14 Apr 2026 · 0 likes P-values and significance: p
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #92 · Clinical › Special populations · 31 Mar 2026 · 1 like Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Started this topic · Analytics › Home & field testing · 19 Mar 2026 · 0 likes Revisiting: Can a home kit substitute for a laboratory report? A careful no — setting out what I have, and where I think it stops being reliable. Working through the…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #69 · Compounds › Cagrilintide & amylin analogues · 16 Mar 2026 · 14 likes Worth separating two things that post #65 runs together. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are…
-
Splitting an overlong document into two Replied, post #6 · Documentation › Wiki requests · 4 Mar 2026 · 22 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Measurement error in a self-reported exposure Replied, post #55 · Evidence › Study critique · 24 Feb 2026 · 32 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #133 · Sourcing › Independent verification · 22 Feb 2026 · 0 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Citation sweep results: how many references did not say what was claimed Replied, post #36 · Meta › Wiki maintenance · 26 Jan 2026 · 22 likes Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages should either be linked or deprecated.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #42 · Clinical › Special populations · 23 Jan 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #34 · Practice › Side effects · 11 Jan 2026 · 18 likes I read post #32 twice before replying, because I had assumed the opposite. Nausea: the most common side effect and the most dose- and titration-dependent one. It is…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #33 · Evidence › Trials · 9 Jan 2026 · 0 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #73 · Sourcing › Independent verification · 8 Jan 2026 · 22 likes post #72 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #87 · Practice › Reconstitution · 27 Nov 2025 · 32 likes Worth separating two things that post #83 runs together. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #28 · Compounds › Other compounds · 16 Nov 2025 · 17 likes On post #24 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #12 · Practice › Side effects · 28 Oct 2025 · 5 likes Coming back to post #10, because the follow-up matters more than the original answer. Injection site reaction: local erythema, nodules, or induration at injection sites…
-
Follow-up: What a seizure notice actually says Replied, post #8 · Sourcing › Logistics · 24 Oct 2025 · 1 like Coming back to post #6, because the follow-up matters more than the original answer. Cold packs and temperature control: inclusion of cold packs at despatch is…
-
Payment mechanics and the recovery options that do not exist Replied, post #27 · Sourcing › Payments · 19 Oct 2025 · 18 likes Currency conversion: payment in your local currency often involves a conversion fee. Paying in the supplier's native currency sometimes saves money, sometimes costs…
-
Sleep tracking data and its considerable limitations Replied, post #16 · Wellbeing › Sleep · 17 Oct 2025 · 14 likes Coming back to post #14, because the follow-up matters more than the original answer. Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The…
-
Compounds this community declines to help with, and why Replied, post #43 · Compounds › Other compounds · 1 Oct 2025 · 20 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #87 · Practice › Side effects · 23 Sep 2025 · 2 likes Coming back to post #85, because the follow-up matters more than the original answer. Nausea: the most common side effect and the most dose- and titration-dependent…
-
Temperature loggers worth the money Replied, post #33 · Devices › Cold chain · 23 Sep 2025 · 6 likes Assessing an excursion: if a package sat at room temperature for a time, visual inspection (cloudiness, discoloration, particles) can alert you to problems. Not visible…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #48 · Compounds › Other compounds · 18 Sep 2025 · 4 likes On post #44 — agreed on the reasoning, with one qualification. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #90 · Evidence › Study critique · 15 Sep 2025 · 13 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #119 · Compounds › Repair & healing peptides · 29 Aug 2025 · 4 likes I read post #117 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is…
-
Column chemistry choices for a 40-residue peptide Replied, post #21 · Analytics › HPLC & UHPLC · 26 Aug 2025 · 3 likes I read post #19 twice before replying, because I had assumed the opposite. This is why a purity figure without the underlying chromatogram is weaker evidence than it…
-
Analytical identity of BPC-157: a 15-mer with a simple mass Replied, post #4 · Compounds › Repair & healing peptides · 26 Aug 2025 · 22 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #97 · Compounds › Retatrutide · 19 Aug 2025 · 4 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #41 · Sourcing › Vendor reports · 17 Aug 2025 · 3 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #3 · Practice › Storage & stability · 15 Aug 2025 · 0 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #90 · Outcomes › Progress reports · 4 Aug 2025 · 11 likes Worth separating two things that post #86 runs together. Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and…
-
A friction point in the promotion workflow Replied, post #2 · Meta › Site feedback · 24 Jul 2025 · 8 likes Feature requests: if the site would work better with a feature it does not have (better search, different filtering, new section) suggest it here with the reasoning.
-
Specification in the result column: why that is a meaningful error Replied, post #21 · Analytics › COA interpretation · 21 Jul 2025 · 4 likes This follows post #18 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Research-use-only labelling: what it means and what it does not Replied, post #12 · Sourcing › Regulatory · 16 Jul 2025 · 0 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
[2026 update] Cold solution and stinging: the simplest fix Replied, post #2 · Practice › Administration · 7 Jul 2025 · 3 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Counter-ion content and its effect on measured mass Replied, post #79 · Analytics › Mass spectrometry · 1 Jul 2025 · 16 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Interim analyses and stopping rules — does this still hold? Replied, post #8 · Evidence › Trials · 25 Jun 2025 · 11 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #6 · Pharmacology › Pharmacokinetics · 18 May 2025 · 3 likes I read post #4 twice before replying, because I had assumed the opposite. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate…
-
Reading order for a first week here, and what to skip until later Replied, post #102 · Start Here › Welcome · 26 Apr 2025 · 0 likes Worth separating two things that post #98 runs together. The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #88 · Devices › Cold chain · 19 Apr 2025 · 0 likes Picking up post #85: that is the part I would want checked first. Shipping container and cold packs: reputable suppliers use insulated containers with cold packs…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #23 · Practice › Storage & stability · 17 Apr 2025 · 6 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #60 · Clinical › Comorbidities · 17 Apr 2025 · 13 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #80 · Practice › Reconstitution · 15 Apr 2025 · 0 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #6 · Sourcing › Vendor reports · 19 Mar 2025 · 1 like Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #119 · Pharmacology › Receptor biology · 18 Mar 2025 · 0 likes This follows post #116 rather than contradicting it. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #89 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes Worth separating two things that post #85 runs together. Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is…
-
Charge states for a 4 kDa peptide, worked through Replied, post #115 · Analytics › Mass spectrometry · 15 Mar 2025 · 14 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Consistent declarations and why they matter more than clever ones Replied, post #129 · Sourcing › Logistics · 5 Mar 2025 · 0 likes post #128 answers the question as asked. The question underneath it is different. Customs outcomes are not predictable at the level of an individual parcel. What is…
-
A promotion I argued against, and why I lost Replied, post #117 · Documentation › Doc review · 2 Mar 2025 · 18 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Scheduled maintenance and what will be unavailable Replied, post #49 · Meta › Announcements · 20 Feb 2025 · 29 likes I read post #47 twice before replying, because I had assumed the opposite. Scheduled maintenance: if the site is going offline for maintenance, advance notice will be…
-
Canadian access and provincial variation Replied, post #38 · Regional › North America · 31 Jan 2025 · 5 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #69 · Compounds › Semaglutide · 23 Dec 2024 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #12 · Compounds › Semaglutide · 17 Dec 2024 · 19 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: When to suspect the method rather than the sample Replied, post #13 · Analytics › Method validation · 30 Nov 2024 · 15 likes Picking up post #10: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
The topic list is dense — is that deliberate? Replied, post #59 · Meta › Site feedback · 28 Nov 2024 · 17 likes Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific situation so staff can clarify or reconsider.
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #18 · Clinical › Special populations · 28 Nov 2024 · 6 likes On post #14 — agreed on the reasoning, with one qualification. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #151 · Compounds › Repair & healing peptides · 26 Nov 2024 · 8 likes post #150 is right about the mechanism and I think understates the practical bit. Oral versus injected administration claims for BPC-157: the preclinical work studied…
-
EMA product information as a primary source — does this still hold? Replied, post #8 · Regional › European Union · 14 Nov 2024 · 20 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Time to steady state after a dose increase Replied, post #30 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 0 likes On post #26 — agreed on the reasoning, with one qualification. Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance…
-
Reading a supplementary appendix and finding the interesting part Replied, post #16 · Evidence › Trials · 2 Nov 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #78 · Clinical › Prescriber conversations · 15 Oct 2024 · 3 likes Picking up post #75: that is the part I would want checked first. Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit…
-
Requesting a page: what makes a good request — what changed since Replied, post #62 · Documentation › Wiki requests · 11 Oct 2024 · 5 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion.
-
Signs of dehydration worth acting on Replied, post #25 · Safety › Adverse events · 5 Oct 2024 · 13 likes Where to report: in many countries there is a pharmacovigilance system where adverse events can be reported. FDA MedWatch in the US, Yellow Card in UK, EudraVigilance…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #24 · Compounds › Other compounds · 30 Sep 2024 · 1 like Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #26 · Analytics › COA interpretation · 9 Aug 2024 · 0 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #14 · Devices › Syringes & needles · 27 Jul 2024 · 22 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Assessing a warm arrival: the decision process — one year on Replied, post #67 · Sourcing › Logistics · 31 May 2024 · 30 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…